Supplementary Figure S3 from A First-in-Human Phase 1 Study of a Tumor-Directed RNA-Interference Drug against HIF2α in Patients with Advanced Clear Cell Renal Cell Carcinoma
Authors:
- James BrugarolasJBJames Brugarolas
- Gregory ObaraGOGregory Obara
- Kathryn E. BeckermannKBKathryn E. Beckermann
- Brian RiniBRBrian Rini
- Elaine T. LamELElaine T. Lam
- James HamiltonJHJames Hamilton
- Thomas SchluepTSThomas Schluep
- Min YiMYMin Yi
- So WongSWSo Wong
- Zhongping Lily MaoZMZhongping Lily Mao
- Erick GamelinEGErick Gamelin
- Nizar M. TannirNTNizar M. Tannir
Open Access
- 3 June 2024
- other
- Published by American Association for Cancer Research (AACR)